Carbohydrate-Based Carriers for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 August 2024) | Viewed by 21058
Special Issue Editors
Interests: drug delivery; anti-inflammatory and analgesic effects; cyclodextrin inclusion complexes; ibuprofen derivatives; chemical synthesis; ionic liquids; polymers
Special Issues, Collections and Topics in MDPI journals
Interests: organic synthesis; chitosan microparticles and nanoparticles; antioxidant activity; diabetes mellitus type 2; drug delivery systems; drug loading; release profile
Special Issues, Collections and Topics in MDPI journals
Interests: anti-inflammatory potential; organic synthesis; nanogels; liposomes; nanocarriers; drug delivery systems
Special Issues, Collections and Topics in MDPI journals
Interests: organic synthesis; drug delivery systems (liposomes, niosomes, chitosan nanoparticles, nanofiber, nanofibers, films, sponges); molecular docking; Structure-Based Drug Design Strategies; antioxidant activity; anti-inflammatory activity; diabetes mellitus type 2
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Carbohydrates, or saccharides, are among the most common molecules found in nature and have biological and structural features that allow for their use in drug delivery systems as carriers. The main classes of these molecules include monosaccharides, oligosaccharides and polisaccharides, which have shown great potential for overcoming the limitations of drugs and navigating biological barriers to achieve targeted delivery. Chitosan, cyclodextrin, alginate, gellan, xanthan gum, cellulose, dextran, pullulan, etc., are some of the most well-known carbohydrate carriers in drug delivery. By protecting the structural integrity of the drug and proving hydrophilic properties, these carriers can modulate undesirable biological properties in drugs as well as their solubility and release profile.
Carbohydrates can improve drug delivery due to their ability to selectively bind to protein receptors, thus increasing drug targeting. They also have the advantages of nontoxicity, biodegradability, good biocompatibility and increased encapsulation stability.
In recent years, carbohydrate-based drug delivery systems have been developed and improved, with their use being of great interest to researchers for the treatment of inflammation, cancer, infections, chronic wounds, diabetes mellitus and other diseases.
This Special Issue will focus on current advances in carbohydrate-based carriers and their applications in drug delivery.
Dr. Ioana Mirela Vasincu
Dr. Florentina Lupascu
Dr. Maria Apotrosoaei
Prof. Dr. Lenuta Profire
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- drug delivery
- release profile
- polisaccharides
- oligosaccharides
- inclusion complexes
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.